2.6 μM (in plasma MPO assay); 0.12 μM (in fluorescent MPO peroxidation assay)
体内研究:
MPO-IN-1 (compound 2) (5 and 90 mg/kg; p.o.; four hours post-Zymosan A administration) significantly reduces MPO activity in a mouse peritonitis model of acute inflammation. Mouse pharmacokinetic parameter of MPO-IN-1.